- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03636425
Musculoskeletal Disorders in Mountain Runners
February 8, 2019 updated by: Paolo Pillastrini, University of Bologna
Prevalence of Musculoskeletal Disorders in Mountain Runners
the study aims to estimate the prevalence of musculoskeletal disorders in a population of runners in the mountains; moreover it proposes to explore the relationship between distance traveled, the difference in height, the training frequency in the week, the shoes worn, the training method, the use of supports and experience of running with musculoskeletal disorders.
The secondary objectives of this study are to investigate to which rehabilitative figures the sportsman turns and if the treatments have positive outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Running is one of the most popular forms of exercise in the world.
The prevalence of musculoskeletal disorders in street runners has already been extensively studied and is about 55% of those affected.
In recent years, more and more runners paid their attention to mountain running where, the different types of terrain and the important differences in height require a different musculoskeletal effort.
In the literature there are few studies that have investigated the prevalence of disorders, risk factors and protective factors on these runners.
The mountain running performed with regularity and method is certainly a healthy activity for individuals, but it is not free from injuries due to several factors, such as long distance, significant differences in level and uneven terrain.
It is not clear whether these factors can influence the onset of skeletal muscle disorders.
The study aims to estimate the prevalence of musculoskeletal disorders in this population of mountain runners; moreover it proposes to explore in this population the relationship between distance traveled, the difference in height, the training frequency in the week, the shoes worn, the training method, the use of supports and experience of running with musculoskeletal disorders.
Moreover, the study wants to investigate to which rehabilitative figures the sportsman turns and if the treatments have positive outcomes.
Inclusion criteria are: age over 18, be a participant of at least one trail, understand the Italian language, to have signed informed consent.
Recruitment: all participants in mountain races will be invited to reply to the attached questionnaire anonymously when the race bib is picked up.
The runners will be free to participate or not in the survey, without the choice can affect the results of the race in any way and can create situations of subjection to the organization.
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Emilia-Romagna
-
Bologna, Emilia-Romagna, Italy, 40138
- University of Bologna
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
mountain runners participating in competitions over the age of 18
Description
Inclusion Criteria:
- age over 18,
- be a participant of at least one mountain race
- understand the Italian language
- have signed an informed consent
Exclusion Criteria:
- under the age of 18
- do not understand Italian language
- not having given consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
presence of musculoskeletal disorders
Time Frame: through study completion, an average of 6 months
|
this outcome is self-reported
|
through study completion, an average of 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Paolo Pillastrini, Bologna University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 30, 2018
Primary Completion (Actual)
January 20, 2019
Study Completion (Actual)
January 30, 2019
Study Registration Dates
First Submitted
August 12, 2018
First Submitted That Met QC Criteria
August 15, 2018
First Posted (Actual)
August 17, 2018
Study Record Updates
Last Update Posted (Actual)
February 11, 2019
Last Update Submitted That Met QC Criteria
February 8, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07082018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Musculoskeletal Diseases
-
Wake Forest University Health SciencesRecruitingMusculoskeletal InjuryUnited States
-
Wroclaw University of Health and Sport SciencesUniversity School of Physical Education, Krakow, PolandCompletedMusculoskeletal DisorderPoland
-
Laval UniversityCompletedMusculoskeletal DisorderCanada
-
Laval UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Singapore General HospitalSengkang General Hospital; Servo DynamicsCompletedWork-related Musculoskeletal DisordersSingapore
-
Vanderbilt UniversityCompletedScapular and Cervical Neuromuscular Control Deficits in Musicians With and Without Playing Injuries.Playing Related Musculoskeletal DisordersUnited States
-
Sheba Medical CenterUnknownWork Related Musculoskeletal DisordersIsrael
-
University Hospital, Clermont-FerrandCompletedSymptomatic Musculoskeletal Diseases | Latent Musculoskeletal DiseasesFrance
-
Aalborg UniversityDagrofa Logistics A/SRecruitingWork-related Musculoskeletal DisordersDenmark
Clinical Trials on Questionnaire administration to gather information
-
Guangzhou Blood CenterCompleted
-
University of PennsylvaniaEnrolling by invitation
-
University of PennsylvaniaFogarty International Center of the National Institute of Health; Universidad...CompletedFood PreferencesGuatemala
-
Fondazione Don Carlo Gnocchi OnlusUnknown
-
Taipei Medical University WanFang HospitalNo longer availableValuable Suggestions to Improve Health Care Quality Transparent and Accessible Medical Care
-
Centre Oscar LambretCentre Hospitalier Universitaire de BesanconTerminated
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedHealth Status UnknownUnited States
-
Istanbul Aydın UniversityCompleted
-
University of New MexicoCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBreast Carcinoma | Fallopian Tube Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Deleterious CDH1 Gene Mutation | Deleterious DICER1 Gene Mutation | Deleterious SMARCA4 Gene Mutation | Deleterious STK11 Gene MutationUnited States